Bill Snyder

July 30, 2020

Protein study may be key to treating fibrotic diseases

A protein linked to amyotrophic lateral sclerosis (ALS), a progressive neurological disease that causes muscle weakness, may be a key to treating fibrotic disease of the kidneys and other organs, researchers at Vanderbilt University Medical Center reported recently.

By Bill Snyder
(iStock)
July 23, 2020

VUMC’s program to repurpose drugs lands international acclaim

Vanderbilt University Medical Center is attracting international attention for its proposal to repurpose existing drugs for new uses in ways that can dramatically improve access to medicines by billions of people throughout the world.

By Bill Snyder
July 23, 2020

Rice named to new leadership role for VICTR operations

Todd Rice, MD, MSc, has been appointed vice president for Clinical Trial Innovation and Operations in the Vanderbilt Institute for Clinical and Translational Research (VICTR).

By Bill Snyder
July 22, 2020

Amidon named 2020 Vanderbilt Prize Student Scholar

Katherine Amidon, a PhD student in the Department of Biological Sciences at Vanderbilt University, has been selected as the 2020 Vanderbilt Prize Student Scholar.

By Bill Snyder
July 20, 2020

Study points to potential new approach to treating neurodegenerative diseases like glaucoma and Alzheimer’s disease

Researchers at Vanderbilt University Medical Center have shown for the first time that when one optic nerve in the eye is damaged, as in glaucoma, the opposite optic nerve comes to the rescue by sharing its metabolic energy.

By Bill Snyder
July 15, 2020

Antibody research at Vanderbilt University Medical Center shows promise in fight against COVID-19

Based on positive results in preclinical studies reported today, potently neutralizing antibodies identified by researchers at Vanderbilt University Medical Center are showing promise as a potential therapy for preventing and treating COVID-19.

By Bill Snyder
July 15, 2020

Vanderbilt University Medical Center to recruit up to 1,000 volunteers for COVID-19 vaccine Trial

In late July, Vanderbilt University Medical Center will begin recruiting up to 1,000 volunteers in a late-stage study of an experimental COVID-19 vaccine developed by Moderna Inc. in collaboration with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.
By Bill Snyder
July 13, 2020

“Nur” target may aid arthritis treatment

Vanderbilt immunologists have discovered that the protein Nur77 is part of a control mechanism that guards against autoimmunity in natural killer T cells.
By Bill Snyder
July 9, 2020

New study supports remdesivir as COVID-19 treatment

This week researchers at Vanderbilt University Medical Center (VUMC), the University of North Carolina at Chapel Hill and Gilead Sciences reported that remdesivir potently inhibited SARS-CoV-2, the virus which causes COVID-19, in human lung cell cultures and that it improved lung function in mice infected with the virus.
By Bill Snyder
July 9, 2020

Autonomic disorders clinical fellowship created

A new Clinical Fellowship in Autonomic Disorders, administered through the Division of Clinical Pharmacology in the Department of Medicine at Vanderbilt University Medical Center, will be one of only four accredited fellowship programs in autonomic disorders in the country.
By Bill Snyder
July 8, 2020

New clues to lung-scarring disease may aid treatment

Scientists at Vanderbilt University Medical Center and the Translational Genomics Research Institute (TGen) in Phoenix, Arizona, have discovered previously unreported genetic and cellular changes that occur in the lungs of people with pulmonary fibrosis (PF).
By Bill Snyder
June 24, 2020

Vanderbilt Institute for Infection, Immunology and Inflammation holds third annual symposium

The Vanderbilt Institute for Infection, Immunology and Inflammation (VI4) held its third annual symposium last week as a virtual, on-line event to preserve social distancing during COVID-19.
By Bill Snyder
1 … 41 42 43 44 45 … 115